{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:02:59Z","timestamp":1789401779685,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd012161","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000}}],"reference-count":216,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012161.pub2","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T10:50:05Z","timestamp":1781866205000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["(Ultra-)short-acting insulin analogues for adults with type 1 diabetes mellitus on multiple daily injections: a network meta-analysis"],"prefix":"10.1002","volume":"2026","author":[{"given":"Yang","family":"Guo","sequence":"additional","affiliation":[{"name":"Cochrane Evidence Synthesis Germany\/UK, D\u00fcsseldorf Subunit, Institute of General Practice, Centre for Health and Society, Medical Faculty; Heinrich Heine University D\u00fcsseldorf; D\u00fcsseldorf Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqian","family":"Mei","sequence":"additional","affiliation":[{"name":"Goethe University Frankfurt; Frankfurt Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Bongaerts","sequence":"additional","affiliation":[{"name":"Cochrane Evidence Synthesis Germany\/UK, D\u00fcsseldorf Subunit, Institute of General Practice, Centre for Health and Society, Medical Faculty; Heinrich Heine University D\u00fcsseldorf; D\u00fcsseldorf Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Inti","family":"Metzendorf","sequence":"additional","affiliation":[{"name":"Institute of General Practice, Centre for Health and Society, Medical Faculty; Heinrich Heine University D\u00fcsseldorf; D\u00fcsseldorf Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Fullerton","sequence":"additional","affiliation":[{"name":"Institute of General Practice; Goethe University; Frankfurt\/Main Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Siebenhofer","sequence":"additional","affiliation":[{"name":"Institute of General Practice and Evidence-Based Health Services Research; Medical University of Graz; Graz Austria"},{"name":"Institute of General Practice; Goethe University; Frankfurt\/Main Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Jeitler","sequence":"additional","affiliation":[{"name":"Institute of General Practice and Evidence-Based Health Services Research; Medical University of Graz; Graz Austria"},{"name":"Institute for Medical Informatics, Statistics and Documentation; Medical University of Graz; Graz Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Horvath","sequence":"additional","affiliation":[{"name":"Institute of General Practice and Evidence-Based Health Services Research; Medical University of Graz; Graz Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Semlitsch","sequence":"additional","affiliation":[{"name":"Institute of General Practice and Evidence-Based Health Services Research; Medical University of Graz; Graz Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Berghold","sequence":"additional","affiliation":[{"name":"Institute for Medical Informatics, Statistics and Documentation; Medical University of Graz; Graz Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Plank","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine; Medical University of Graz; Graz Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandi L","family":"Siegfried","sequence":"additional","affiliation":[{"name":"Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0411-899X","authenticated-orcid":false,"given":"Juan VA","family":"Franco","sequence":"additional","affiliation":[{"name":"Cochrane Evidence Synthesis Germany\/UK, D\u00fcsseldorf Subunit, Institute of General Practice, Centre for Health and Society, Medical Faculty; Heinrich Heine University D\u00fcsseldorf; D\u00fcsseldorf Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"10.1002\/14651858.CD012161.pub2-BIB0001|cit1","volume-title":"StatPearls [Internet]","author":"Lucier","year":"2025"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0002|cit2","volume-title":"Endotext [Internet]","author":"Donnor","year":"2023"},{"issue":"10","key":"10.1002\/14651858.CD012161.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.2337\/dc12-2109","article-title":"The long-term effects of type 1 diabetes treatment and complications on health-related quality of life: a 23-year follow-up of the Diabetes Control and Complications\/Epidemiology of Diabetes Interventions and Complications cohort","volume":"36","author":"Jacobson","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM19930930329140","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"The Diabetes Control and Complications Trial Research Group (DCCT)","year":"1993","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012161.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/pedi.13137","article-title":"Worldwide differences in childhood type 1 diabetes: the SWEET experience","volume":"22","author":"Saiyed","year":"2020","journal-title":"Pediatric Diabetes"},{"issue":"6","key":"10.1002\/14651858.CD012161.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1056\/NEJM198908103210605","article-title":"The physiological replacement of insulin: an elusive goal","volume":"321","author":"Zinman","year":"1989","journal-title":"New England Journal of Medicine"},{"issue":"10","key":"10.1002\/14651858.CD012161.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.2337\/diacare.21.10.1726","article-title":"Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes","volume":"21","author":"Brunelle","year":"1998","journal-title":"Diabetes Care"},{"issue":"17","key":"10.1002\/14651858.CD012161.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1001\/jama.289.17.2254","article-title":"Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review","volume":"289","author":"DeWitt","year":"2003","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD012161.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/S0149-2918(97)80014-8","article-title":"Efficacy of insulin lispro in combination with NPH human insulin twice per day in patients with insulin-dependent or non-insulin dependent diabetes","volume":"19","author":"Vignati","year":"1997","journal-title":"Clinical Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD012161.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF01059088","article-title":"Modeling absorption kinetics of subcutaneous injected soluble insulin","volume":"17","author":"Mosekilde","year":"1989","journal-title":"Journal of Pharmacokinetics and Biopharmaceutics"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"396","DOI":"10.2337\/diab.43.3.396","article-title":"[Lys(B28),Pro(B29)]-human insulin A rapidly absorbed analogue of human insulin","volume":"43","author":"Howey","year":"1994","journal-title":"Diabetes"},{"issue":"7","key":"10.1002\/14651858.CD012161.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/BF00417697","article-title":"Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM","volume":"37","author":"Torlone","year":"1994","journal-title":"Diabetologia"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0013|cit13","unstructured":"National Health Service (NHS) About rapid-acting insulin - Brand names: Admelog, Apidra, Fiasp, Humalog, Lyumjev, NovoRapid, Trurapi https:\/\/www.nhs.uk\/medicines\/insulin\/rapid-acting-insulin\/about-rapid-acting-insulin\/ 2023"},{"issue":"2","key":"10.1002\/14651858.CD012161.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1177\/19322968231204584","article-title":"The role of ultra-rapid-acting insulin analogs in diabetes: an expert consensus","volume":"19","author":"Giorgino","year":"2023","journal-title":"Journal of Diabetes Science and Technology"},{"issue":"10","key":"10.1002\/14651858.CD012161.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"e70122","DOI":"10.1111\/dme.70122","article-title":"Fully closed-loop control with ultra-rapid versus standard insulin lispro: a randomised crossover study simulating missed meal boluses","volume":"42","author":"Thabit","year":"2025","journal-title":"Diabetic Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012161.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2337\/cd20-0119","article-title":"Ultra-rapid-acting insulins: how fast is really needed?","volume":"39","author":"Wong","year":"2021","journal-title":"Clinical Diabetes"},{"issue":"2","key":"10.1002\/14651858.CD012161.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s40262-019-00834-5","article-title":"Fast-acting insulin aspart: a review of its pharmacokinetic and pharmacodynamic properties and the clinical consequences","volume":"59","author":"Haahr","year":"2020","journal-title":"Clinical Pharmacokinetics"},{"issue":"11","key":"10.1002\/14651858.CD012161.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1007\/s40262-021-01030-0","article-title":"Ultra rapid Lispro (URLi) accelerates insulin Lispro absorption and insulin action vs Humalog(\u00ae) consistently across study populations: a pooled analysis of pharmacokinetic and glucodynamic data","volume":"60","author":"Leohr","year":"2021","journal-title":"Clinical Pharmacokinetics"},{"issue":"4","key":"10.1002\/14651858.CD012161.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1503\/cmaj.081041","article-title":"Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis","volume":"180","author":"Singh","year":"2009","journal-title":"Canadian Medical Association Journal"},{"issue":"6","key":"10.1002\/14651858.CD012161.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1463-1326.2006.00686.x","article-title":"Insulin-associated weight gain in diabetes - causes, effects and coping strategies","volume":"9","author":"Russell-Jones","year":"2007","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/BF00400229","article-title":"Insulin-like growth factor I acts as an angiogenic agent in rabbit cornea and retina: comparative studies with basic fibroblast growth factor","volume":"36","author":"Grant","year":"1993","journal-title":"Diabetologia"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1172\/JCI111764","article-title":"Receptors and growth-promoting effects of insulin and insulin-like growth factors on cells from bovine retinal capillaries and aorta","volume":"75","author":"King","year":"1985","journal-title":"Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0023|cit23","first-page":"A3","article-title":"Carciogenic effect of the human insulin analogue B10 Asp in female rats","volume":"35 Suppl 1","author":"J\u00f8rgensen","year":"1992","journal-title":"Diabetologia"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"999","DOI":"10.2337\/diabetes.49.6.999","article-title":"Correlation of receptor binding and metabolic and metogenic potencies of insulin analogues designed for clinical use","volume":"49","author":"Kurtzhals","year":"2000","journal-title":"Diabetes"},{"issue":"9","key":"10.1002\/14651858.CD012161.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1007\/s00125-009-1418-4","article-title":"Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study","volume":"52","author":"Hemkens","year":"2009","journal-title":"Diabetologia"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/(SICI)1096-9136(199607)13:7&lt;683::AID-DIA144&gt;3.0.CO;2-1","article-title":"Time-action profile of the insulin analogue B28Asp","volume":"13","author":"Heinemann","year":"1996","journal-title":"Diabetic Medicine"},{"issue":"5","key":"10.1002\/14651858.CD012161.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1210\/edrv.19.5.0343","article-title":"The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease","volume":"19","author":"Haffner","year":"1998","journal-title":"Endocrine Reviews"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0168-8227(98)00132-6","article-title":"Injection-meal interval: recommendations of diabetologists and how patients handle it","volume":"43","author":"Overmann","year":"1999","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"5","key":"10.1002\/14651858.CD012161.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1046\/j.1464-5491.2000.00289.x","article-title":"Post-prandial administration of the insulin analogue insulin aspart in patients with type 1 diabetes mellitus","volume":"17","author":"Brunner","year":"2000","journal-title":"Diabetic Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012161.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"570","DOI":"10.2337\/diacare.21.4.570","article-title":"Postprandial insulin lispro: a new therapeutic option for type 1 diabetic patients","volume":"21","author":"Schernthaner","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"e075681","DOI":"10.1136\/bmj-2023-075681","article-title":"New advances in type 1 diabetes","volume":"384","author":"Subramanian","year":"2024","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD012161.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"486","DOI":"10.4158\/EP09294.RA","article-title":"Rapid-acting insulin analogues in basal-bolus regimens in type 1 diabetes mellitus","volume":"16","author":"Garg","year":"2010","journal-title":"Endocrine Practice"},{"issue":"11","key":"10.1002\/14651858.CD012161.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diabres.2006.10.015","article-title":"A review of human and analogue insulin trials","volume":"77","author":"Gough","year":"2007","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0034|cit34","unstructured":"Review of the evidence comparing insulin (human or animal) with analogue insulins 18th Expert Committee on the Selection and Use of Essential Medicines Accra, Ghana World Health Organization (WHO)"},{"issue":"4","key":"10.1002\/14651858.CD012161.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1503\/cmaj.081180","article-title":"Cost-effectiveness of insulin analogues for diabetes mellitus","volume":"180","author":"Cameron","year":"2009","journal-title":"Canadian Medical Association Journal"},{"issue":"2","key":"10.1002\/14651858.CD012161.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"e000258","DOI":"10.1136\/bmjopen-2011-000258","article-title":"Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin","volume":"1","author":"Holden","year":"2011","journal-title":"BMJ Open"},{"issue":"4","key":"10.1002\/14651858.CD012161.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00125-007-0922-7","article-title":"Modern insulins - comment on facts and assumptions in a recent Editorial","volume":"51","author":"Frick","year":"2008","journal-title":"Diabetologia"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"d5675","DOI":"10.1136\/bmj.d5675","article-title":"Commentary: politics of affordable insulin","volume":"343","author":"Gale","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s00125-007-0763-4","article-title":"Nice insulins, pity about the evidence","volume":"50","author":"Holleman","year":"2007","journal-title":"Diabetologia"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"d5858","DOI":"10.1136\/bmj.d5858","article-title":"Commentary: does additional benefit justify additional costs of insulin analogues?","volume":"343","author":"Sawicki","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0041|cit41","volume-title":"Section 18. Medicines for endocrine disorders: 18.5. Medicines for diabetes","year":"2025"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"d5782","DOI":"10.1136\/bmj.d5782","article-title":"The prickly problem of access to insulin","volume":"343","year":"2011","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD012161.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"e001832","DOI":"10.1136\/bmjdrc-2020-001832","article-title":"Efficacy, safety and cost-effectiveness comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go wearable insulin delivery device in type 2 diabetes","volume":"8","author":"Mora","year":"2020","journal-title":"BMJ Open Diabetes Research & Care"},{"issue":"4","key":"10.1002\/14651858.CD012161.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2337\/dc18-1850","article-title":"Real-world costs of continuous insulin pump therapy and multiple daily injections for type 1 diabetes: a population-based and propensity-matched cohort from the Swedish National Diabetes Register","volume":"42","author":"Toresson Grip","year":"2019","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1002\/14651858.CD012161.pub2-BIB0045|cit45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012161","article-title":"Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus","author":"Fullerton","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0046|cit46","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0047|cit47","volume-title":"Methodological Expectations of Cochrane Intervention Reviews. Version August 2023. https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/mecir-manual","author":"Higgins","year":"2023"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012161.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"S150","DOI":"10.2337\/dc26-S007","article-title":"7. Diabetes technology: standards of care in diabetes - 2026","volume":"49","author":"American Diabetes Association Professional Practice Committee for Diabetes (ADAPPCD)","year":"2026","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0050|cit50","unstructured":"Franco JV Bongaerts B Guo Y Metzendorf MI (Ultra-)short-acting insulin analogues for adults with type 1 diabetes mellitus: an updated systematic review and network meta-analysis https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD42024599817 2024"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0051|cit51","unstructured":"R: A language and environment for statistical computing R Foundation for Statistical Computing 2024"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0052|cit52","unstructured":"How CENTRAL is created https:\/\/www.cochranelibrary.com\/central\/central-creation"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0053|cit53","volume-title":"Methodological Expectations of Cochrane Intervention Reviews","author":"Higgins","year":"2016"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"g1687","DOI":"10.1136\/bmj.g1687","article-title":"Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide","volume":"348","author":"Hoffmann","year":"2014","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"j2998","DOI":"10.1136\/bmj.j2998","article-title":"Enhancing the usability of systematic reviews by improving the consideration and description of interventions","volume":"358","author":"Hoffmann","year":"2017","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0056|cit56","doi-asserted-by":"crossref","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JA Chapter 8: Assessing risk of bias in a randomized trial (last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch8"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD012161.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v106.i02","article-title":"netmeta: an R package for network meta-analysis using frequentist methods","volume":"106","author":"Balduzzi","year":"2023","journal-title":"Journal of Statistical Software"},{"issue":"16","key":"10.1002\/14651858.CD012161.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1002\/sim.8158","article-title":"Network meta-analysis of rare events using the Mantel-Haenszel method","volume":"38","author":"Efthimiou","year":"2019","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking treatments in frequentist network meta-analysis works without resampling methods","volume":"15","author":"R\u00fccker","year":"2015","journal-title":"BMC Medical Research Methodology"},{"issue":"2","key":"10.1002\/14651858.CD012161.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD012161.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1136\/bmjebm-2021-111904","article-title":"The complexity underlying treatment rankings: how to use them and what to look at","volume":"28","author":"Chiocchia","year":"2023","journal-title":"BMJ Evidence-Based Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012161.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/dmrr.202","article-title":"Severe hypoglycaemia in patients with type 1 diabetes and impaired awareness of hypoglycaemia: a comparative study of insulin lispro and regular human insulin","volume":"17","author":"Ferguson","year":"2001","journal-title":"Diabetes\/Metabolism Research and Reviews"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0064|cit64","unstructured":"Short acting insulin analogues for the treatment of type 1 diabetes mellitus https:\/\/www.iqwig.de\/download\/A05-02_Abschlussbericht_Kurzwirksame_Insulinanaloga_bei_Diabetes_mellitus_Typ_1.pdf 2007"},{"issue":"3","key":"10.1002\/14651858.CD012161.pub2-BIB0065|cit65","first-page":"133","article-title":"Lispro insulin in type 1 diabetic patients on a Mediterranean or normal diet: a randomized, cross-over comparative study with regular insulin","volume":"14","author":"Provenzano","year":"2001","journal-title":"Diabetes, Nutrition & Metabolism"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0066|cit66","doi-asserted-by":"crossref","unstructured":"Higgins JP Eldridge S Li T Chapter 23: Including variants on randomized trials (last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch23"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0067|cit67","unstructured":"Deeks JJ Higgins JP Altman DG McKenzie JE Veroniki AA Chapter 10: Analysing data and undertaking meta-analyses (last updated November 2024). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0068|cit68","unstructured":"Page MJ Higgins JP Sterne JA Chapter 13: Assessing risk of bias due to missing evidence in a meta-analysis (last updated August 2024). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0069|cit69","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2026"},{"issue":"24","key":"10.1002\/14651858.CD012161.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1002\/(sici)1097-0258(19961230)15:24&lt;2733::Aid-sim562&gt;3.0.Co;2-0","article-title":"Borrowing strength from external trials in a meta-analysis","volume":"15","author":"Higgins","year":"1996","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012161.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/0962280207080643","article-title":"Evaluation of networks of randomized trials","volume":"17","author":"Salanti","year":"2008","journal-title":"Statistical Methods in Medical Research"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"d549","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"Riley","year":"2011","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD012161.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/jrsm.1045","article-title":"Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression","volume":"3","author":"White","year":"2012","journal-title":"Research Synthesis Methods"},{"issue":"1","key":"10.1002\/14651858.CD012161.pub2-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1164","article-title":"Methods to estimate the between-study variance and its uncertainty in meta-analysis","volume":"7","author":"Veroniki","year":"2016","journal-title":"Research Synthesis Methods"},{"issue":"1","key":"10.1002\/14651858.CD012161.pub2-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2288-14-25","article-title":"The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method","volume":"14","author":"IntHout","year":"2014","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0076|cit76","unstructured":"World Bank country and lending groups https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0077|cit77","doi-asserted-by":"crossref","unstructured":"Chaimani A Caldwell DM Li T Higgins JP Salanti G Chapter 11: Undertaking network meta-analyses (last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch11"},{"issue":"2","key":"10.1002\/14651858.CD012161.pub2-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"130","DOI":"10.7326\/0003-4819-159-2-201307160-00008","article-title":"Conceptual and technical challenges in network meta-analysis","volume":"159","author":"Cipriani","year":"2013","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012161.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/1741-7015-11-159","article-title":"Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers","volume":"11","author":"Jansen","year":"2013","journal-title":"BMC Medicine"},{"issue":"7521","key":"10.1002\/14651858.CD012161.pub2-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/bmj.331.7521.897","article-title":"Simultaneous comparison of multiple treatments: combining direct and indirect evidence","volume":"331","author":"Caldwell","year":"2005","journal-title":"BMJ"},{"issue":"20","key":"10.1002\/14651858.CD012161.pub2-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1002\/sim.1875","article-title":"Combination of direct and indirect evidence in mixed treatment comparisons","volume":"23","author":"Lu","year":"2004","journal-title":"Statistics in Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012161.pub2-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/ije\/dys222","article-title":"Evaluation of inconsistency in networks of interventions","volume":"42","author":"Veroniki","year":"2013","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/1471-2288-12-138","article-title":"Simulation evaluation of statistical properties of methods for indirect and mixed treatment comparisons","volume":"12","author":"Song","year":"2012","journal-title":"BMC Medical Research Methodology"},{"issue":"1","key":"10.1002\/14651858.CD012161.pub2-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1471-2288-14-106","article-title":"Characteristics of a loop of evidence that affect detection and estimation of inconsistency: a simulation study","volume":"14","author":"Veroniki","year":"2014","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0085|cit85","unstructured":"Welch VA Petkovic J Jull J Hartling L Klassen T Kristjansson E Chapter 16: Equity and specific populations (last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"issue":"4","key":"10.1002\/14651858.CD012161.pub2-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"e1003082","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: an approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLOS Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012161.pub2-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"e1080","DOI":"10.1002\/cl2.1080","article-title":"CINeMA: software for semiautomated assessment of the confidence in the results of network meta-analysis","volume":"16","author":"Papakonstantinou","year":"2020","journal-title":"Campbell Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD012161.pub2-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"e99682","DOI":"10.1371\/journal.pone.0099682","article-title":"Evaluating the quality of evidence from a network meta-analysis","volume":"9","author":"Salanti","year":"2014","journal-title":"PLOS One"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jclinepi.2019.04.018","article-title":"Development of the summary of findings table for network meta-analysis","volume":"115","author":"Yepes-Nu\u00f1ez","year":"2019","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0090|cit90","unstructured":"Insulin Glulisine in type 1 diabetes mellitus https:\/\/clinicaltrials.gov\/study\/NCT00297583"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0091|cit91","unstructured":"Schade DS Pre-meal insulin analogue insulin Lispro vs. Humulin\u00ae insulin treatment in young subjects with type I diabetes Unknown 1996 9 4 238-40"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0092|cit92","unstructured":"Short acting insulin analogues for the treatment of type 1 diabetes mellitus https:\/\/www.iqwig.de\/download\/A05-02_Abschlussbericht_Kurzwirksame_Insulinanaloga_bei_Diabetes_mellitus_Typ_1.pdf 2007"},{"issue":"1","key":"10.1002\/14651858.CD012161.pub2-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/s0149-2918(97)80073-2","article-title":"Improved mealtime treatment of diabetes mellitus using an insulin analogue","volume":"19","author":"Anderson","year":"1997","journal-title":"Clinical Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD012161.pub2-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/(SICI)1096-9136(199601)13:1&lt;47::AID-DIA999&gt;3.0.CO;2-M","article-title":"Pre-meal insulin analogue insulin lispro vs humulin insulin treatment in young subjects with type 1 diabetes","volume":"13","author":"Garg","year":"1996","journal-title":"Diabetic Medicine"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/dom.15317","article-title":"Ultra-rapid lispro improved postprandial glucose control compared to insulin lispro in predominantly Chinese patients with type 1 diabetes: a prospective, randomized, double-blind phase 3 study","volume":"26","author":"Ma","year":"2024","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0096|cit96","unstructured":"Zhou Z Ma J Lei T An Z Xue Y Manghi FP Efficacy and safety of ultra-rapid lispro compared to insulin lispro in adults with type 1 diabetes 58th EASD Annual Meeting Stockholm European Association for the Study of Diabetes (EASD) 2022 S3642022 10.1007\/s00125-022-05755-w"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0097|cit97","unstructured":"A study of LY900014 compared to insulin Lispro (Humalog) in adults with type 1 diabetes https:\/\/clinicaltrials.gov\/study\/NCT03952130"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0098|cit98","unstructured":"A study of LY900014 in participants with type 1 diabetes (PRONTO-T1D) https:\/\/clinicaltrials.gov\/study\/NCT03214367?tab=results"},{"issue":"11","key":"10.1002\/14651858.CD012161.pub2-BIB0099|cit99","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1089\/dia.2020.0129","article-title":"Ultra-rapid Lispro improves postprandial glucose control and time in range in type 1 diabetes compared to Lispro: PRONTO-T1D continuous glucose monitoring substudy","volume":"22","author":"Malecki","year":"2020","journal-title":"Diabetes Technology & Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD012161.pub2-BIB0100|cit100","doi-asserted-by":"publisher","first-page":"108648","DOI":"10.1016\/j.jdiacomp","article-title":"Fasting and postprandial plasma glucose contributions to hemoglobin A1c and time in range in people with diabetes on multiple daily injection insulin therapy: results from the PRONTO-T1D and PRONTO-T2D clinical trials","volume":"38","author":"Piras de Oliveira","year":"2024","journal-title":"Journal of Diabetes and its Complications"},{"issue":"2","key":"10.1002\/14651858.CD012161.pub2-BIB0101|cit101","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s13300-020-00987-8","article-title":"Long-term efficacy and safety of ultra-rapid Lispro (URLi) in adults with type 1 diabetes: the PRONTO-T1D extension","volume":"12","author":"Bue-Valleskey","year":"2021","journal-title":"Diabetes Therapy"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0102|cit102","doi-asserted-by":"crossref","unstructured":"Bue-Valleskey JM Cho JI Hardy T The impact of basal insulin type, prandial dosing plan, and baseline postprandial glucose (PPG) on glycemic control after treatment with ultra-rapid lispro (URLI) or humalog in type 1 diabetes: planned subgroup analyses from pronto-T1D Diabetes 2020 1044 P https:\/\/doi.org\/10.2337\/db20-1044-P","DOI":"10.2337\/db20-1044-P"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0103|cit103","unstructured":"Bue-Valleskey JM Klaff LJ Cho J Dellva MA Schloot N Miura J Long-term safety and efficacy of ultra-rapid Lispro (URLi) in PRONTO-T1D Diabetologia 2020 S328-9 10.1007\/s00125-020-05221-5"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0104|cit104","unstructured":"Comparison of LY900014 to insulin Lispro in adults with type 1 diabetes https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=CTRI\/2017\/09\/009591"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0105|cit105","doi-asserted-by":"crossref","unstructured":"Klaff LJ Cho J Dellva MA Schloot NC Tobian J Miura J Long-term safety and efficacy of ultra-rapid lispro (URLI) in pronto-T1D Diabetes 2020 232 OR 10.2337\/db20-232-OR","DOI":"10.2337\/db20-232-OR"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0106|cit106","unstructured":"A study in people with type 1 diabetes to determine how well a meal-time insulin, LY900014, controls diabetes compared to Humalog (insulin lispro) when both are used along with a long-acting insulin https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2015-005356-99\/results"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0107|cit107","unstructured":"A phase 3 study of LY900014 when added to insulin treatment in patients with type 1 diabetes https:\/\/jrct.mhlw.go.jp\/latest-detail\/jRCT2080223613"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0108|cit108","doi-asserted-by":"crossref","unstructured":"Malecki M Cao D Liu R Hardy TA Bode BW Bue-Valleskey JM Ultra rapid lispro (URLi) improves postprandial glucose control and time in range in type 1 diabetes compared to lispro: PRONTO-T1D continuous glucose monitoring sub-study Diabetologia 2019 S3832019 10.1007\/s00125-019-4946-6","DOI":"10.1089\/dia.2020.0129"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0109|cit109","unstructured":"De Oliveira CP Dellva MA Bue-Valleskey JM Chang AM Chigutsa FB Liao B Relative contribution of fasting plasma and postprandial glucose to HbA1c and tir in people with T1D on basal-bolus insulin therapy Diabetes 2021 107 LB 10.2337\/db21-107-LB"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0110|cit110","doi-asserted-by":"crossref","unstructured":"Klaff L Cao D Dellva MA Tobian J Miura J Dahl D Ultra-rapid lispro (URLi) improves postprandial glucose control vs Humalog\u00ae (Lispro) in type 1 diabetes: PRONTO-T1D study Diabetes, Metabolism Research and Reviews 2019 e3222 10.1002\/dmrr.3222","DOI":"10.2337\/db19-144-OR"},{"issue":"9","key":"10.1002\/14651858.CD012161.pub2-BIB0111|cit111","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1007\/s13300-021-01124-9","article-title":"Long-term efficacy and safety of ultra rapid Lispro in Japanese patients with type 1 diabetes: subpopulation analysis of the 52-week PRONTO-T1D study","volume":"12","author":"Miura","year":"2021","journal-title":"Diabetes Therapy"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0112|cit112","doi-asserted-by":"crossref","unstructured":"Klaff LJ Cao D Dellva MA Tobian J Miura J Dahl D Ultra rapid Lispro (URLI) improves postprandial glucose (PPG) control vs. Humalog (Lispro) in T1D: PRONTO-T1D study Diabetes 2019 144 OR 10.2337\/db19-144-OR","DOI":"10.2337\/db19-144-OR"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0113|cit113","doi-asserted-by":"crossref","unstructured":"Cho JI Bue-Valleskey J Hardy T Effect of stratification factors and baseline postprandial glucose on glycaemic control after 26 weeks of Ultra Rapid Lispro (URLi) or Lispro: subgroup analyses of PRONTO-type 1 diabetes Diabetologia 2020 S3272020 10.1007\/s00125-020-05221-5","DOI":"10.1055\/s-0041-1727328"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0114|cit114","unstructured":"Dahl D Cao D Dellva M Tobian JA Miura J Klaff L Ultra rapid lispro (URLi) improves postprandial glucose (PPG) control vs lispro in type 1 diabetes: PRONTO-T1D study Diabetologia 2019 S932019 10.1007\/s00125-019-4946-6"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0115|cit115","unstructured":"Bue-Valleskey J Bode B Malecki M Cao D Liu R Hardy T Ultra rapid lispro (URLI) improves postprandial glucose (PPG) control and time in range (TIR) in T1D compared to lispro: pronto-T1D continuous glucose monitoring (CGM) sub-study Diabetes Technology & Therapeutics 2020 Suppl 1 10.1089\/dia.2020.2525.abstracts"},{"issue":"9","key":"10.1002\/14651858.CD012161.pub2-BIB0116|cit116","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1007\/s13300-020-00892-0","article-title":"Ultra-rapid Lispro efficacy and safety compared to Humalog\u00ae in Japanese patients with type 1 diabetes: PRONTO-T1D subpopulation analysis","volume":"11","author":"Miura","year":"2020","journal-title":"Diabetes Therapy"},{"issue":"10","key":"10.1002\/14651858.CD012161.pub2-BIB0117|cit117","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1111\/dom.14100","article-title":"Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: results from the 26-week PRONTO-T1D study","volume":"22","author":"Klaff","year":"2020","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0118|cit118","doi-asserted-by":"crossref","unstructured":"Cho JI Bue-Valleskey J Hardy T Goergens S Effect of stratification factors and baseline postprandial glucose on glycemic control after treatment with ultra rapid lispro or Humalog: subgroup analyses of PRONTO-T1D Diabetologie und Stoffwechsel 2021 S162021 10.1055\/s-0041-1727328","DOI":"10.1055\/s-0041-1727328"},{"issue":"3","key":"10.1002\/14651858.CD012161.pub2-BIB0119|cit119","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/s0168-8227(03)00036-6","article-title":"Insulin lispro is as effective as regular insulin in optimising metabolic control and preserving \u03b2-cell function at onset of type 1 diabetes mellitus","volume":"60","author":"Recasens","year":"2003","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0120|cit120","unstructured":"Short acting insulin analogues for the treatment of type 1 diabetes mellitus https:\/\/www.iqwig.de\/download\/A05-02_Abschlussbericht_Kurzwirksame_Insulinanaloga_bei_Diabetes_mellitus_Typ_1.pdf 2007"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0121|cit121","unstructured":"Short acting insulin analogues for the treatment of type 1 diabetes mellitus https:\/\/www.iqwig.de\/download\/A05-02_Abschlussbericht_Kurzwirksame_Insulinanaloga_bei_Diabetes_mellitus_Typ_1.pdf 2007"},{"issue":"1","key":"10.1002\/14651858.CD012161.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/(SICI)1096-9136(199601)13:1<47::AID-DIA999>3.0.CO;2-M","article-title":"Pre-meal insulin analogue insulin lispro vs humulin insulin treatment in young subjects with type 1 diabetes","volume":"13","author":"Garg","year":"1996","journal-title":"Diabetic Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012161.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0149-2918(97)80073-2","article-title":"Improved mealtime treatment of diabetes mellitus using an insulin analogue","volume":"19","author":"Anderson","year":"1997","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0124|cit124","unstructured":"Short acting insulin analogues for the treatment of type 1 diabetes mellitus https:\/\/www.iqwig.de\/download\/A05-02_Abschlussbericht_Kurzwirksame_Insulinanaloga_bei_Diabetes_mellitus_Typ_1.pdf 2007"},{"issue":"1","key":"10.1002\/14651858.CD012161.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/(SICI)1096-9136(199601)13:1<47::AID-DIA999>3.0.CO;2-M","article-title":"Pre-meal insulin analogue insulin lispro vs humulin insulin treatment in young subjects with type 1 diabetes","volume":"13","author":"Garg","year":"1996","journal-title":"Diabetic Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012161.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0149-2918(97)80073-2","article-title":"Improved mealtime treatment of diabetes mellitus using an insulin analogue","volume":"19","author":"Anderson","year":"1997","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0127|cit127","unstructured":"Short acting insulin analogues for the treatment of type 1 diabetes mellitus https:\/\/www.iqwig.de\/download\/A05-02_Abschlussbericht_Kurzwirksame_Insulinanaloga_bei_Diabetes_mellitus_Typ_1.pdf 2007"},{"issue":"1","key":"10.1002\/14651858.CD012161.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/(SICI)1096-9136(199601)13:1<47::AID-DIA999>3.0.CO;2-M","article-title":"Pre-meal insulin analogue insulin lispro vs Humulin R insulin treatment in young subjects with type 1 diabetes","volume":"13","author":"Garg","year":"1996","journal-title":"Diabetic Medicine"},{"issue":"11","key":"10.1002\/14651858.CD012161.pub2-BIB0129|cit129","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1046\/j.1464-5491.2000.00380.x","article-title":"Insulin aspart vs. human insulin in the management of long-term blood glucose control in type 1 diabetes mellitus: a randomized controlled trial","volume":"17","author":"Home","year":"2000","journal-title":"Diabetic Medicine"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0130|cit130","unstructured":"Safety and efficacy of insulin aspart in subjects with type 1 diabetes https:\/\/clinicaltrials.gov\/study\/NCT01707134"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0131|cit131","unstructured":"Short acting insulin analogues for the treatment of type 1 diabetes mellitus https:\/\/www.iqwig.de\/download\/A05-02_Abschlussbericht_Kurzwirksame_Insulinanaloga_bei_Diabetes_mellitus_Typ_1.pdf 2007"},{"issue":"2","key":"10.1002\/14651858.CD012161.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.diabres.2005.05.015","article-title":"Pre-meal insulin aspart compared with pre-meal soluble human insulin in type 1 diabetes","volume":"71","author":"Home","year":"2006","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1046\/j.1464-5491.2003.01010.x","article-title":"Effect of the rapid-acting insulin analogue insulin aspart on quality of life and treatment satisfaction in patients with type 1 diabetes","volume":"20","author":"Bott","year":"2003","journal-title":"Diabetic Medicine"},{"issue":"10","key":"10.1002\/14651858.CD012161.pub2-BIB0134|cit134","doi-asserted-by":"publisher","first-page":"799","DOI":"10.11213\/tonyobyo1958.44.799","article-title":"Comparison between insulin aspart and soluble human insulin in type 1 diabetes (IDDM) patients treated with basal-bolus insulin therapy - Phase III clinical trial in Japan","volume":"44","author":"Iwamoto","year":"2001","journal-title":"Journal of the Japan Diabetes Society"},{"issue":"5","key":"10.1002\/14651858.CD012161.pub2-BIB0135|cit135","doi-asserted-by":"publisher","first-page":"583","DOI":"10.2337\/diacare.23.5.583","article-title":"Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes","volume":"23","author":"Raskin","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0136|cit136","unstructured":"Short acting insulin analogues for the treatment of type 1 diabetes mellitus htpps\/\/www.iqwig.de\/download\/A05-02_Abschlussbericht_Kurzwirksame_Insulinanaloga_bei_Diabetes_mellitus_Typ_1.pdf 2007"},{"issue":"11","key":"10.1002\/14651858.CD012161.pub2-BIB0137|cit137","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1055\/s-2005-870584","article-title":"Efficacy and safety of insulin glulisine in patients with type 1 diabetes","volume":"37","author":"Dreyer","year":"2005","journal-title":"Hormone and Metabolic Research"},{"issue":"9","key":"10.1002\/14651858.CD012161.pub2-BIB0138|cit138","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1463-1326.2009.01086.x","article-title":"Efficacy and safety of insulin glulisine in Japanese patients with type 1 diabetes mellitus","volume":"11","author":"Kawamori","year":"2009","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0139|cit139","unstructured":"Efficacy and safety of insulin glulisine in type 1 diabetes mellitus https:\/\/clinicaltrials.gov\/study\/NCT00290979"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0140|cit140","unstructured":"Efficacy and safety of FIAsp compared to insulin Aspart both in combination with insulin Detemir in adults with type 1 diabetes https:\/\/www.novonordisk-trials.com\/study-results.html"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0141|cit141","unstructured":"Bode B Mathieu C Franek E Philis-Tsimikas A Rose L Graungaard T Onset 1: efficacy and safety of mealtime fast-acting insulin aspart versus insulin aspart after 52 weeks Diabetes Technology & Therapeutics 2018 A292018 10.1089\/dia.2018.2525.abstracts"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0142|cit142","unstructured":"Leelarathna L Philis-Tsimikas A Bode BW Franek E Rose L Buchholtz K Improved glycaemic control with carbohydrate counting for adjustment of fast-acting insulin aspart vs insulin aspart in subjects with type 1 diabetes Diabetic Medicine 2018 19 10.1111\/dme.6_13570"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0143|cit143","unstructured":"Sethi BK De Block A Carlson A Rose L Gondolf T Gorst-Rasmussen A Hypoglycemia with mealtime fast-acting insulin aspart versus insulin aspart across two large type 1 diabetes trials Indian Journal of Endocrinology and Metabolism 2018 S21 10.4103\/22308210.245111"},{"issue":"12","key":"10.1002\/14651858.CD012161.pub2-BIB0144|cit144","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1111\/dom.13026","article-title":"Projected long-term outcomes in patients with type 1 diabetes treated with fast-acting insulin aspart vs conventional insulin aspart in the UK setting","volume":"19","author":"Russell-Jones","year":"2017","journal-title":"Diabetes, Obesity and Metabolism"},{"issue":"5","key":"10.1002\/14651858.CD012161.pub2-BIB0145|cit145","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s40262-018-0718-6","article-title":"Clinical pharmacology of fast-acting insulin Aspart versus insulin Aspart measured as free or total insulin Aspart and the relation to anti-insulin Aspart antibody levels in subjects with type 1 diabetes mellitus","volume":"58","author":"Haahr","year":"2019","journal-title":"Clinical Pharmacokinetics"},{"issue":"3","key":"10.1002\/14651858.CD012161.pub2-BIB0146|cit146","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s13300-019-0608-4","article-title":"Efficacy and safety of fast-acting insulin Aspart in people with type 1 diabetes using carbohydrate counting: a post-hoc analysis of two randomised controlled trials","volume":"10","author":"Rose","year":"2019","journal-title":"Diabetes Therapy"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0147|cit147","unstructured":"Mathieu C Bode BW Franek E Philistsimikas A Rose L Graungaard T Efficacy and safety of fast-acting insulin aspart are maintained over 52 weeks: comparison with insulin aspart in onset 1 Diabetes 2017 A258 10.1007\/s00125-017-4350-z"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0148|cit148","unstructured":"Mathieu C Bode B Franek E Philis-Tsimikas A Rose L Graungaard T Efficacy and safety of fast-acting insulin aspart are maintained over 52 weeks: comparison with insulin aspart in onset 1 Diabetologia 2017 S314"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0149|cit149","unstructured":"Russell-Jones D Heller SR Woo VC Babu V Dethlefsen C Mathieu C The impact of baseline BMI and HbA1c on glycemic control after treatment with mealtime fast-acting insulin aspart in people with type 1 diabetes Diabetology & Metabolic Syndrome 2018 27 10.1186\/s13098-018-0315-8"},{"issue":"7","key":"10.1002\/14651858.CD012161.pub2-BIB0150|cit150","doi-asserted-by":"publisher","first-page":"943","DOI":"10.2337\/dc16-1771","article-title":"Fast-acting insulin Aspart improves glycemic control in basal-bolus treatment for type 1 diabetes: results of a 26-week multicenter, active-controlled, treat-to-target, randomized, parallel-group trial (onset 1)","volume":"40","author":"Russell-Jones","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0151|cit151","unstructured":"Efficacy and safety of FIAsp compared to insulin Aspart both in combination with insulin Detemir in adults with type 1 diabetes (onset\u00ae 1) https:\/\/clinicaltrials.gov\/study\/NCT01831765"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0152|cit152","unstructured":"Russell-Jones D Bode BW De Block C Franek E Heller S Mathieu C Double-blind mealtime faster-acting insulin aspart improves glycaemic control with superior reduction in postprandial glucose excursions vs insulin aspart in type 1 diabetes: onset\u00ae 1 Diabetologia 2016 S6"},{"issue":"5","key":"10.1002\/14651858.CD012161.pub2-BIB0153|cit153","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/dom.13205","article-title":"Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): a 52-week, randomized, treat-to-target, phase III trial","volume":"20","author":"Mathieu","year":"2018","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0154|cit154","doi-asserted-by":"crossref","unstructured":"De Block C Carlson A Rose L Gondolf T Gorst-Rasmussen A Lane W Hypoglycemia with mealtime fast-acting insulin Aspart vs. insulin Aspart across two large type 1 diabetes trials Diabetes 2018 10.2337\/db18-96-LB","DOI":"10.2337\/db18-96-LB"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0155|cit155","doi-asserted-by":"crossref","unstructured":"Russell-Jones D Bode BW De Block C Franek E Heller SR Mathieu C Double-blind mealtime faster-acting insulin aspart vs. insulin aspart in basal-bolus improves glycemic control in T1D: the onset\u00ae 1 trial Diabetes 2016 A77","DOI":"10.1016\/j.jcjd.2016.08.162"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0156|cit156","unstructured":"Russell-Jones D Bode BW De Block C Franek E Heller S Mathieu C Improved glycaemic control and superior reduction of PPG increments with double-blind mealtime faster-acting insulin aspart vs conventional insulin aspart in T1D: the onset 1 trial Diabetes Technology & Therapeutics 2017 A29-A30 10.1089\/dia.2017.2525.abstracts"},{"issue":"1","key":"10.1002\/14651858.CD012161.pub2-BIB0157|cit157","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s13300-018-0553-7","article-title":"Investigating the association between baseline characteristics (HbA1c and body mass index) and clinical outcomes of fast-acting insulin Aspart in people with diabetes: a post-hoc analysis","volume":"10","author":"Bowering","year":"2019","journal-title":"Diabetes Therapy"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0158|cit158","doi-asserted-by":"crossref","unstructured":"Heller S Bowering K Raskin P Liebl A Buchholtz K Demissie M 1,5-anhydroglucitol correlates with postprandial glucose in subjects with type 1 diabetes irrespective of hba1c responder status Diabetes Technology & Therapeutics 2018 A31-2 10.1089\/dia.2018.2525.abstracts","DOI":"10.26226\/morressier.59d51842d462b80296ca3619"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0159|cit159","unstructured":"Efficacy and safety of faster-acting insulin Aspart compared to NovoRapid\u00ae both in combination with insulin Degludec in adults with type 1 diabetes (onset\u00ae8) https:\/\/www.novonordisk-trials.com\/study-results.html"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0160|cit160","unstructured":"Pieber TR Buse J Rose L Gorst-Rasmussen A Boesgaard TW Buchholtz K Glycaemic control with fast-acting insulin aspart according to dose adjustment method in type 1 diabetes: a post hoc analysis of onset 8 Diabetologia 2018 S398-9 10.1007\/s00125-018-4693-0"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0161|cit161","unstructured":"Usefulness and safety of faster-acting insuin Aspart is being compared to NovoRapid (fast-acting insulin) both in combination with marketed product Tresiba (insulin Degludec) in adults with type-1 diabetes https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=CTRI\/2016\/06\/007031"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0162|cit162","unstructured":"Efficacy and safety of faster-acting insulin Aspart compared to NovoRapid\u00ae both in combination with insulin Degludec in adults with type 1 diabetes https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2015-001047-36\/results"},{"issue":"4","key":"10.1002\/14651858.CD012161.pub2-BIB0163|cit163","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1507\/endocrj.EJ20-0606","article-title":"Efficacy and safety of fast-acting insulin aspart compared with insulin aspart in combination with insulin degludec in Japanese adults with type 1 diabetes: a subgroup analysis of the randomized onset 8 trial","volume":"68","author":"Komatsu","year":"2021","journal-title":"Endocrine Journal"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0164|cit164","doi-asserted-by":"crossref","unstructured":"Buse JB Carlson A Komatsu M Mosenzon O Rose L Liang B Efficacy and safety of faster aspart compared with insulin aspart both with insulin degludec in adults with T1D Diabetes 2018 A261-2","DOI":"10.2337\/db18-1000-P"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0165|cit165","unstructured":"Efficacy and safety of faster-acting insulin Aspart compared to NovoRapid\u00ae both in combination with insulin Degludec in adults with type 1 diabetes (onset\u00ae8) https:\/\/clinicaltrials.gov\/study\/NCT02500706"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0166|cit166","unstructured":"Bhansali A Buse J Carlson A Komatsu M Mosenzon O Rose L Efficacy and safety of faster Aspart compared with insulin Aspart both with insulin Degludec in adults with T1D Diabetes 2018"},{"issue":"12","key":"10.1002\/14651858.CD012161.pub2-BIB0167|cit167","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1111\/dom.13545","article-title":"Fast-acting insulin aspart versus insulin aspart in the setting of insulin degludec-treated type 1 diabetes: efficacy and safety from a randomized double-blind trial","volume":"20","author":"Buse","year":"2018","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0168|cit168","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1046\/j.1464-5491.2003.01010.x","article-title":"Effect of the rapid-acting insulin analogue insulin aspart on quality of life and treatment satisfaction in patients with type 1 diabetes","volume":"20","author":"Bott","year":"2003","journal-title":"Diabetic Medicine"},{"issue":"5","key":"10.1002\/14651858.CD012161.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"876","DOI":"10.2337\/diacare.25.5.876","article-title":"Immune responses to insulin aspart and biphasic insulin aspart in people with type 1 and type 2 diabetes","volume":"25","author":"Lindholm","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1007\/s001250051065","article-title":"Risk factors of severe hypoglycaemia in adult patients with type 1 diabetes - a prospective population based study","volume":"41","author":"Muehlhauser","year":"1998","journal-title":"Diabetologia"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0171|cit171","unstructured":"Diabetes Medicines Management Advisory Group (DMMAG) Insulin guidelines for adults and children with type 1 or type 2 diabetes mellitus The National Health Service (NHS) England 2021 1 30"},{"issue":"1 Suppl 1","key":"10.1002\/14651858.CD012161.pub2-BIB0172|cit172","doi-asserted-by":"publisher","first-page":"S181","DOI":"10.2337\/dc25-S009","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2025","volume":"48","author":"American Diabetes Association Professional Practice Committee (ADAPPC)","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0173|cit173","first-page":"S1","volume-title":"Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada","volume":"42","author":"McGibbon","year":"2018"},{"issue":"3","key":"10.1002\/14651858.CD012161.pub2-BIB0174|cit174","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/dme.13525","article-title":"Optimal prandial timing of bolus insulin in diabetes management: a review","volume":"35","author":"Slattery","year":"2018","journal-title":"Diabetic Medicine"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0175|cit175","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1046\/j.1464-5491.2003.01018.x","article-title":"Are analogue insulins better than soluble in continuous subcutaneous insulin infusion? Results of a meta-analysis","volume":"20","author":"Colquitt","year":"2003","journal-title":"Diabetic Medicine"},{"issue":"11","key":"10.1002\/14651858.CD012161.pub2-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1007\/s00125-013-3007-9","article-title":"Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case-control study","volume":"56","author":"Johnson","year":"2013","journal-title":"Diabetologia"},{"issue":"1","key":"10.1002\/14651858.CD012161.pub2-BIB0177|cit177","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/dmrr.2653","article-title":"Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics","volume":"32","author":"Pozzilli","year":"2015","journal-title":"Diabetes\/Metabolism Research and Reviews"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0178|cit178","doi-asserted-by":"publisher","first-page":"110144","DOI":"10.1016\/j.diabres.2022.110144","article-title":"Efficacy and safety of ultra-rapid insulin analogues in insulin pumps in patients with type 1 diabetes mellitus: a systematic review and meta-analysis","volume":"193","author":"Stamati","year":"2022","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"16","key":"10.1002\/14651858.CD012161.pub2-BIB0179|cit179","doi-asserted-by":"publisher","first-page":"1600157","DOI":"10.3389\/fendo.2025.1600157","article-title":"Ultra-rapid lispro or fast-acting aspart compared to standard insulin lispro and aspart using closed-loop insulin therapy: a systematic review and meta-analysis of randomized control trials","volume":"2","author":"Rakab","year":"2025","journal-title":"Frontiers in Endocrinology"},{"issue":"3","key":"10.1002\/14651858.CD012161.pub2-BIB0180|cit180","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2337\/diacare.25.3.439","article-title":"Comparison of insulin aspart with buffered regular insulin and insulin lispro in continuous subcutaneous insulin infusion","volume":"25","author":"Bode","year":"2002","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1002\/14651858.CD012161.pub2-BIB0181|cit181","first-page":"192","article-title":"Improved blood glucose variability, HbA1c Insuman Infusat and less insulin requirement in IDDM patients using insulin lispro in CSII. The Swedish multicenter lispro insulin study","volume":"26","author":"Johansson","year":"2000","journal-title":"Diabetes Metabolism"},{"issue":"5","key":"10.1002\/14651858.CD012161.pub2-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2337\/diacare.22.5.784","article-title":"Use of insulin lispro in continuous subcutaneous insulin infusion treatment","volume":"22","author":"Renner","year":"1999","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1002\/14651858.CD012161.pub2-BIB0183|cit183","doi-asserted-by":"publisher","first-page":"440","DOI":"10.2337\/diab.46.3.440","article-title":"Insulin lispro in CSII: results of a double-blind crossover study","volume":"46","author":"Zinman","year":"1997","journal-title":"Diabetes"},{"issue":"8","key":"10.1002\/14651858.CD012161.pub2-BIB0184|cit184","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1007\/s11606-021-06642-7","article-title":"Comparative efficacy and safety of ultra-long-acting, long-acting, intermediate-acting, and biosimilar insulins for type 1 diabetes mellitus: a systematic review and network meta-analysis","volume":"36","author":"Tricco","year":"2021","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0185|cit185","unstructured":"National Institute for Health and Care Excellence (NICE) Type 1 diabetes in adults. Quality standard QS208; 2 March 2023 https:\/\/www.nice.org.uk\/guidance\/qs208\/chapter\/Quality-statement-2-Continuous-glucose-monitoring"},{"issue":"1","key":"10.1002\/14651858.CD012161.pub2-BIB0186|cit186","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1297\/cpe.30.1","article-title":"Time in range centered diabetes care","volume":"30","author":"Dovc","year":"2021","journal-title":"Clinical Pediatric Endocrinology"},{"issue":"5","key":"10.1002\/14651858.CD012161.pub2-BIB0187|cit187","doi-asserted-by":"publisher","first-page":"782","DOI":"10.2337\/dci23-0092","article-title":"Time in tight range for patients with type 1 diabetes: the time is now, or is it too soon?","volume":"47","author":"Hamidi","year":"2024","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1002\/14651858.CD012161.pub2-BIB0188|cit188","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1177\/19322968251333441","article-title":"The use of continuous glucose monitoring to diagnose stage 2 type 1 diabetes","volume":"19","author":"Mader","year":"2025","journal-title":"Journal of Diabetes Science and Technology"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0189|cit189","doi-asserted-by":"publisher","first-page":"116808","DOI":"10.1016\/j.biopha.2024.116808","article-title":"Revolutionizing type 1 diabetes management: exploring oral insulin and adjunctive treatments","volume":"176","author":"Nabi-Afjadi","year":"2024","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0190|cit190","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1464-5491.2005.01781.x","article-title":"Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross-over trial in people with type 1 diabetes","volume":"23","author":"Ashwell","year":"2006","journal-title":"Diabetic Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012161.pub2-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s00125-004-1365-z","article-title":"Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes","volume":"47","author":"Hermansen","year":"2004","journal-title":"Diabetologia"},{"issue":"9","key":"10.1002\/14651858.CD012161.pub2-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1463-1326.2012.01580.x","article-title":"The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences","volume":"14","year":"2012","journal-title":"Diabetes, Obesity and Metabolism"},{"issue":"7","key":"10.1002\/14651858.CD012161.pub2-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/S2213-8587(14)70073-7","article-title":"Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trial","volume":"2","author":"Pedersen-Bjergaard","year":"2014","journal-title":"Lancet Diabetes & Endocrinology"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0194|cit194","volume-title":"Short-Acting Insulin Analogues for Diabetes Mellitus: Meta-Analysis of Clinical Outcomes and Assessment of Cost-Effectiveness (Technology Report No 87)","author":"Banerjee","year":"2007"},{"issue":"3","key":"10.1002\/14651858.CD012161.pub2-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.diabet.2010.12.003","article-title":"Efficacy and safety comparison of rapid-acting insulin aspart and regular human insulin in the treatment of type 1 and type 2 diabetes mellitus: a systematic review","volume":"37","author":"Rys","year":"2011","journal-title":"Diabetes & Metabolism"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0196|cit196","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13098-018-0397-3","article-title":"Short-acting insulin analogues versus regular human insulin on postprandial glucose and hypoglycemia in type 1 diabetes mellitus: a systematic review and meta-analysis","volume":"11","author":"Melo","year":"2019","journal-title":"Diabetology & Metabolic Syndrome"},{"issue":"9","key":"10.1002\/14651858.CD012161.pub2-BIB0197|cit197","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s00592-019-01326-5","article-title":"Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials","volume":"56","author":"Pala","year":"2019","journal-title":"Acta Diabetologica"},{"issue":"3","key":"10.1002\/14651858.CD012161.pub2-BIB0198|cit198","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s13300-019-00732-w","article-title":"Rapid-acting insulin analogues versus regular human insulin: a meta-analysis of effects on glycemic control in patients with diabetes","volume":"11","author":"Nicolucci","year":"2020","journal-title":"Diabetes Therapy"},{"issue":"9","key":"10.1002\/14651858.CD012161.pub2-BIB0199|cit199","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1111\/dom.14773","article-title":"What is the value of faster acting prandial insulin? Focus on ultra rapid lispro","volume":"24","author":"Heise","year":"2022","journal-title":"Diabetes, Obesity and Metabolism"},{"issue":"11","key":"10.1002\/14651858.CD012161.pub2-BIB0200|cit200","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.18553\/jmcp.2016.22.11.1224","article-title":"A systematic review of insulin adherence measures in patients with diabetes","volume":"22","author":"Stolpe","year":"2016","journal-title":"Journal of Managed Care & Specialty Pharmacy"},{"issue":"3","key":"10.1002\/14651858.CD012161.pub2-BIB0201|cit201","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2337\/diaspect.29.3.166","article-title":"Adherence to insulin therapy","volume":"29","author":"Sarbacker","year":"2016","journal-title":"Diabetes Spectrum"},{"issue":"4","key":"10.1002\/14651858.CD012161.pub2-BIB0202|cit202","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/children12040463","article-title":"Evaluating treatment adherence in children and adolescents with type 1 diabetes: the impact of the Adherence Starts with Knowledge-12 Score on metabolic control","volume":"12","author":"Dilek","year":"2025","journal-title":"Children (Basel)"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0203|cit203","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/1753-0407.12060","article-title":"Meta-analysis of insulin aspart versus regular human insulin used in a basal-bolus regimen for the treatment of diabetes mellitus","volume":"5","author":"Heller","year":"2013","journal-title":"Journal of Diabetes"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0204|cit204","first-page":"168","article-title":"Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type 1 diabetic patients: a multicenter randomized crossover trial","volume":"11","author":"Annuzzi","year":"2001","journal-title":"Nutrition, Metabolism, and Cardiovascular Diseases"},{"issue":"12","key":"10.1002\/14651858.CD012161.pub2-BIB0205|cit205","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.2337\/diacare.20.12.1827","article-title":"Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro","volume":"20","author":"Holleman","year":"1997","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1002\/14651858.CD012161.pub2-BIB0206|cit206","doi-asserted-by":"publisher","first-page":"e001410","DOI":"10.1136\/bmjgh-2019-001410","article-title":"Insulin prices, availability and affordability in 13 low-income and middle-income countries","volume":"4","author":"Ewen","year":"2019","journal-title":"BMJ Global Health"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0207|cit207","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ejim.2024.11.018","article-title":"Treatment of hospitalized patient with hyperglycemia: an EFIM critically appraised and adapted guideline","volume":"132","author":"Uyaro\u011flu","year":"2025","journal-title":"European Journal of Internal Medicine"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012161.pub2-BIB0208|cit208","doi-asserted-by":"publisher","first-page":"S159","DOI":"10.1210\/clinem\/dgae790","article-title":"Navigating insulin options for diabetes management","volume":"110","author":"Rafi","year":"2025","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012161.pub2-BIB0209|cit209","first-page":"A34","article-title":"Faster-acting insulin aspart improves postprandial glycaemia versus insulin aspart in patients with type 1 diabetes mellitus","volume":"63","author":"Heise","year":"2014","journal-title":"Diabetes"},{"key":"10.1002\/14651858.CD012161.pub2-BIB0210|cit210","unstructured":"Kaye J Krasner A Canney L Pichotta P Simms P Krishnarajah J Novel formulations BIOD-238 and BIOD-250 result in more rapid absorption and declines from peak than Humalog Proceeding of the 49th Annual Meeting of the European Association for the Study of Diabetes Barcelona, Spain European Association for the Study of Diabetes (EASD) S413"},{"issue":"4","key":"10.1002\/14651858.CD012161.pub2-BIB0211|cit211","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1177\/193229681200600408","article-title":"A review of a family of ultra-rapid-acting insulins: formulation development","volume":"6","author":"Krasner","year":"2012","journal-title":"Journal of Diabetes Science and Technology"},{"issue":"8","key":"10.1002\/14651858.CD012161.pub2-BIB0212|cit212","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.2337\/dc11-0182","article-title":"Improved pharmacokinetic and pharmacodynamic profile of rapid-acting insulin using needle-free jet injection technology","volume":"34","author":"Engwerda","year":"2011","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1002\/14651858.CD012161.pub2-BIB0213|cit213","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/dmrr.2536","article-title":"Improved pharmacokinetic and pharmacodynamic profiles of insulin analogues using InsuPatch, a local heating device","volume":"30","author":"Landau","year":"2014","journal-title":"Diabetes\/Metabolism Research and Reviews"},{"issue":"10","key":"10.1002\/14651858.CD012161.pub2-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1185\/03007995.2014.933098","article-title":"Standardized modulation of the injection site allows for insulin dose reduction without deterioration of metabolic control","volume":"30","author":"Pf\u00fctzner","year":"2014","journal-title":"Current Medical Research & Opinion"},{"issue":"5","key":"10.1002\/14651858.CD012161.pub2-BIB0215|cit215","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD016351","article-title":"Insulin regimens for adults living with type 1 diabetes mellitus","author":"Taneri","year":"2026","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012161.pub2-BIB0216|cit216","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003287.pub4","article-title":"Short acting insulin analogues versus regular human insulin inpatients with diabetes mellitus","author":"Siebenhofer","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:07:27Z","timestamp":1789398447000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012161.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":216,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012161.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]}}}